Examination Report |
1 | Additional Representation Sheet | 12 Aug 2015 |
2 | TM-1 | 12 Aug 2015 |
3 | Reply to Exam Report (MIS-R) | 26 Aug 2016 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 10 Jul 2018 |
5 | TM-M(EXTENSION OF TIME) | 24 Jul 2018 |
6 | Documents in support of Show cause Hearing (SCH) | 05 Feb 2019 |
7 | Authorization Letter | 06 Feb 2019 |
8 | Journal Copy | 09 May 2019 |
9 | Certificate | 05 Jul 2019 |
1 | Dispatching of Examination Report for : 3030523 | 3766238 | 1864892 | 18 Jul 2016 |
2 | Hearing Notice (Show Cause) | 6442698 | 2969801 | 30 May 2018 |
3 | Hearing notice (Adjourned) | 7501620 | 3682488 | 20 Dec 2018 |
4 | Tribunal Accepted Notice for : 3030523 | 7739330 | 3753788 | 06 Feb 2019 |
The application for Acenomac was made on 12 August 2015.
The trademark applicant for Acenomac is MACLEODS PHARMACEUTICALS.
Acenomac is applied in class(es) 5.
Application for Acenomac is on Registered stage.
Application Id allotted to Acenomac is 3030523.
Trademark agent or attorney for the application is Singh & Singh Law Firm Llp.
Acenomac filed with the Intellectual property office as a WORD.